Gainers
- Kaleido Biosciences KLDO stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6 million.
- Iterum Therapeutics ITRM stock rose 14.24% to $0.39. The company's market cap stands at $70.3 million.
- Creative Medical Tech CELZ stock rose 10.38% to $2.02. The market value of their outstanding shares is at $12.7 million.
- Also check out: Executives Buy Around $1M Of 5 Penny Stocks
- Aerie Pharmaceuticals AERI shares moved upwards by 10.16% to $6.5. The market value of their outstanding shares is at $307.8 million. As per the press release, Q4 earnings came out yesterday.
- Aquestive Therapeutics AQST shares increased by 8.87% to $2.7. The company's market cap stands at $108.4 million.
- Axcella Health AXLA stock rose 7.95% to $1.9. The market value of their outstanding shares is at $73.9 million.
Losers
- Baudax Bio BXRX shares declined by 54.3% to $2.0 during Friday's pre-market session. The company's market cap stands at $4.8 million.
- Midatech Pharma MTP shares decreased by 15.29% to $0.82. The company's market cap stands at $10.3 million.
- Cardiff Oncology CRDF shares fell 13.86% to $2.3. The market value of their outstanding shares is at $96.5 million. The company's, Q4 earnings came out yesterday.
- Synlogic SYBX stock declined by 13.05% to $1.6. The market value of their outstanding shares is at $111.5 million.
- OPKO Health OPK shares declined by 12.7% to $2.82. The company's market cap stands at $1.9 billion. As per the press release, Q4 earnings came out yesterday.
- Clearside Biomedical CLSD shares declined by 10.96% to $1.3. The market value of their outstanding shares is at $77.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in